Minerva Surgical, Inc.
NASDAQ:UTRS
0.0001 (USD) • At close January 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 50.294 | 52.103 | 37.768 | 26.012 |
| Cost of Revenue
| 23.052 | 21.58 | 18.648 | 14.207 |
| Gross Profit
| 27.242 | 30.523 | 19.12 | 11.805 |
| Gross Profit Ratio
| 0.542 | 0.586 | 0.506 | 0.454 |
| Reseach & Development Expenses
| 5.443 | 5.292 | 3.324 | 0.935 |
| General & Administrative Expenses
| 14.37 | 22.183 | 8.212 | 8.382 |
| Selling & Marketing Expenses
| 38.328 | 32.193 | 22.974 | 22.125 |
| SG&A
| 52.698 | 54.376 | 31.186 | 30.507 |
| Other Expenses
| 0 | -0.34 | 0.071 | 0.171 |
| Operating Expenses
| 58.141 | 59.668 | 34.51 | 31.442 |
| Operating Income
| -30.899 | -29.145 | -15.39 | -19.637 |
| Operating Income Ratio
| -0.614 | -0.559 | -0.407 | -0.755 |
| Total Other Income Expenses Net
| -3.202 | 7.69 | -3.005 | -32.409 |
| Income Before Tax
| -34.101 | -21.455 | -18.395 | -52.046 |
| Income Before Tax Ratio
| -0.678 | -0.412 | -0.487 | -2.001 |
| Income Tax Expense
| 0.011 | 0.009 | -0.132 | 17.75 |
| Net Income
| -34.112 | -21.464 | -18.263 | -69.796 |
| Net Income Ratio
| -0.678 | -0.412 | -0.484 | -2.683 |
| EPS
| -23.68 | -61.22 | -17.91 | -75.29 |
| EPS Diluted
| -23.68 | -61.22 | -17.91 | -75.29 |
| EBITDA
| -20.073 | -18.855 | -8.162 | -17.656 |
| EBITDA Ratio
| -0.399 | -0.362 | -0.216 | -0.679 |